Full Year Revenue Above Guidance
Fiscal 2026 revenue of $2.1 billion came in above the high end of the guided range and was $2 million above prior year, demonstrating resilience versus expectations.
We use cookies to improve your experience, analyze site usage, and show relevant ads. Go to our Privacy Policy for details.
The call presented a predominantly positive operational and financial picture: key strengths include higher-education share gains (approaching 31%), recurring revenue growth (~6% to $1.5B), margin expansion (≈+80 bps), meaningful AI product traction (8 tools, >7.5M users), strong learning outcomes validated by independent research, and significant debt reduction ($646M). Headwinds are concentrated in K–12 (FY2026 K–12 revenue down 9%), slower-than-expected California math adoption (timing shift of ~$100M), international macro pressures (FY2026 international revenue -7% and a $39M impairment), and some one-time benefits in FY2026 that are not recurring. Management provided conservative but above-IPO-expectations guidance for recurring revenue and EBITDA, and is piloting agentic AI/knowledge models with commercial and pricing work still underway. Overall, strengths in higher education, AI-enabled product adoption, cash generation, and balance sheet improvement outweigh the K–12 and international timing challenges, which are framed as addressable and timing-related.
McGraw Hill guided fiscal 2027 revenue of $2.115–$2.175 billion (consistent with its IPO dollar outlook), recurring revenue of $1.587–$1.627 billion, and adjusted EBITDA of $750–$790 million (implied margin ~35.9% at the midpoint, ~+50 bps YoY); it expects ~55% of full‑year revenue in H1 (weighted to Q2), unlevered free cash flow of ~ $400 million (up ~20% YoY), CapEx and product development ~10% of revenue, stock‑based compensation ~ $15 million, cash/GAAP taxes $20–$40 million, GAAP interest expense below $180 million, and a modest decline in depreciation & amortization (including $208 million of Platinum‑related intangible amortization); management reiterated a net‑leverage target of 2.0–2.5x and authorized a $50 million share repurchase plan.
Fiscal 2026 revenue of $2.1 billion came in above the high end of the guided range and was $2 million above prior year, demonstrating resilience versus expectations.
Recurring revenue grew ~6% year-over-year to $1.5 billion and now represents over 73% of total revenue. In the fourth quarter, recurring revenue was $373 million (81% of total) and digital revenue was $393 million (85% of total).
Higher education revenue grew 12% year-over-year to $879 million for FY2026, with Q4 higher ed revenue up nearly 2% to $258 million. Market share reached ~31% (approaching 31% per MPI) and the company recorded its 40th consecutive quarter of higher ed share gains; net dollar retention in higher ed was 114%.
Fiscal year adjusted EBITDA was $744 million, up ~2% year-over-year, with adjusted EBITDA margin expanding by nearly 80 basis points to 35.4%. Q4 adjusted EBITDA was $131 million with margins expanding ~40 basis points year-over-year; Q4 gross margin increased ~50 basis points.
Cash from operations was $331 million and the company generated $335 million of unlevered free cash flow in FY2026. Management reduced gross debt by $646 million during the year, ended the year with $254 million cash and $704 million total liquidity, and repurchased $40 million of high-coupon notes in the open market.
Launched eight AI learning tools serving more than 7.5 million users, with three additional launches planned. Company highlighted a proprietary content and data moat: >100 million active licenses (students & educators), ~25.6 billion learning interactions captured, and ~190 terabytes of learning data to tune education-specific AI.
Independent research validated meaningful outcomes: ALEKS students achieved topic mastery >90% of the time; example district results included first graders +25 points and second graders +55 points in math assessments; Sharpen users at Rowan College had final exam scores 47% higher than non-users; AI Reader drove 57 million interactions across 2.4 million students.
FY2027 guidance: revenue $2.115B–$2.175B, recurring revenue $1.587B–$1.627B, adjusted EBITDA $750M–$790M (implied margin ~35.9% at midpoint, +50 bps YoY). Unlevered free cash flow guidance ~$400M (≈+20% YoY). Board authorized a $50 million share repurchase plan and management reiterated a disciplined capital allocation focus (reinvestment, debt reduction, selective tuck-ins).
strengthening the core, expanding our cross-sell opportunities, growing our addressable market, and driving operational efficiencies. In K through 12, we're continuing to evolve our California math program to meet the emerging requirements of the market. This California math adoption cycle has been slower than expected, but 80% of the market remains undecided. Also, in K12, we're entering one of the most important nationwide curriculum refresh cycles in this millennium, as an unprecedented amount of schools evaluate new English Language Arts programs. Since 2021, we've invested over $100 million in our new science of reading ELA program, Emerge!, Summit!, and Soar!. This is our largest curriculum investment to date, and we are seeing early district wins and a strong rubric of scores ahead of emerging opportunities. In higher education, we continue to gain share as institutions adopt inclusive access, expand their use of our Evergreen model, and seek more integrated learning experiences. fiscal fourth quarter marked our 40th consecutive quarter of market share gains in higher ed, with our share approaching 31% according to MPI.
Our Net Promoter Score reached a record in the spring, and we saw strong retention and volume growth. We've also seen solid adoption of our new offerings in credentialing and AI professional development. Within our global professional business, medical education represents more than 75% of revenue. The World Health Organization projects a shortage of 11 million healthcare workers by 2030, and this year we expanded our offerings into clinical traini...
June 11th, 2026
February 11th, 2026
November 12th, 2025